Professor, Internal Medicine, Mayo Medical School
Allergy & Immunology
Dr. Joseph H. Butterfield, MD
|
|
Give Review
Doctor Joseph H. Butterfield, MD works in the field of Allergy & Immunology. Joseph Butterfield is also a published doctor. He has 100 publication published. The most recent publication is: Elevated serum levels of calcitonin gene-related peptide in Hymenoptera sting-induced anaphylaxis. Joseph Butterfield is registered with Medicare.
Publications
- Refractory intraoperative hypotension with elevated serum tryptase.
- Mast Cell Sarcoma: Clinical Management.
- Clonal mast cell disease not meeting WHO criteria for diagnosis of mastocytosis: clinicopathologic features and comparison with indolent mastocytosis.
- Systemic mastocytosis in the elderly.
- Mortality in hypereosinophilic syndrome: 19 years of experience at Mayo Clinic with a review of the literature.
- ICON: Eosinophil Disorders.
- Use of pegylated interferon in hypereosinophilic syndrome.
- Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal.
- Primary headache syndromes in systemic mastocytosis.
- Neurologic symptoms and diagnosis in adults with mast cell disease.
- Predicting which medication classes interfere with allergy Skin testing.
- Increased leukotriene E4 excretion in systemic mastocytosis.
- Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib ...
- Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy.
- Frequency of Allergic or hematologic adverse reactions to ticlopidine among patients with Allergic or hematologic adverse reactions to clopidogrel.
- Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors.
- Survey of aspirin administration in systemic mastocytosis.
- Clostridium difficile toxins A and B directly stimulate human mast cells.
- Treatment of hypereosinophilic syndromes with prednisone, hydroxyurea, and interferon.
- Asthma treatment in a population-based cohort: putting step-up and step-down treatment changes in context.
- Allergen-specific in vitro cytokine production in adult patients with eosinophilic esophagitis.
- Eosinophilic oophoritis: association with positive Strongyloides stercoralis serology and clinical response to ivermectin.
- Systemic mastocytosis: clinical manifestations and differential diagnosis.
- Treatment of Asthma with nebulized lidocaine: a randomized, placebo-controlled study.
- Bone marrow biopsies for the diagnosis of systemic mastocytosis: is one biopsy sufficient?
- Systemic mast cell disease without associated hematologic disorder: a combined retrospective and prospective study.
- Urticarial vasculitis with asymptomatic Chronic hepatitis C infection: response to doxepin, interferon-alfa, and ribavirin.
- Effects of rhinovirus infection on histamine and cytokine production by cell lines from human mast cells and basophils.
- Eosinophilic gastroenteritis and gluten-sensitive enteropathy in the same patient.
- Human eosinophils produce neurotrophins and secrete nerve growth factor on immunologic stimuli.
- The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor se...
- Bone marrow angiogenesis in systemic mast cell disease.
- Polyunsaturated fatty acids stimulate superoxide formation in tumor cells: a mechanism for specific cytoToxicity and a model for tumor necrosis factor?
- The role of cortisone in the production of peptic esophagitis in the cat.
- The circulation in diabetes, from HL523 to the NO era.
- Dr Gilbert''s magnetism.
- UKPDS: what was the question? UK Prospective Diabetes Study.
- Lectin histochemistry of human leukaemic mast cells (HMC-1) transplanted into severe combined immunodeficient (scid) mice.
- The human mast cell chymase gene (CMA1): mapping to the cathepsin G/granzyme gene cluster and lineage-restricted expression.
- 5-Lipoxygenase upregulation by dexamethasone in human mast cells.
- Evidence for secretion of human eosinophil granule major basic protein and Charcot-Leyden crystal protein during eosinophil maturation.
- Elevated serum levels in human pregnancy of a molecule immunochemically similar to eosinophil granule major basic protein.
- Localization of a molecule immunochemically similar to eosinophil major basic protein in human placenta.
- Mast cell Pharyngitis as a cause of supraglottic edema.
- Atypical periorbital xanthogranulomas associated with systemic benign lymphoepithelial lesions.
- Eosinophil-associated inflammation and elaboration of eosinophil-derived proteins in 2 children with raccoon roundworm (Baylisascaris procyonis) encephalitis.
- Mast cell infiltration and degranulation in colonic mucosa in the irritable bowel syndrome.
- Expression of multiple chemokine genes by a human mast cell leukemia.
- Human lung mast cell activation leads to IL-13 mRNA expression and protein release.
- The human mast cell line HMC-1 expresses C5a receptors and responds to C5a but not to C5a(desArg).
- Mast cells are a major source of basic fibroblast growth factor in Chronic inflammation and cutaneous hemangioma.
- IFN-gamma-stimulated enhancement of MHC class II antigen expression by the human mast cell line HMC-1.
- Specific inhibition of beta-tryptase expression in a human mast cell line by granulocyte-macrophage colony-stimulating factor produced by airways structural cells.
- Production of macrophage inflammatory protein-1alpha by human mast cells: increased anti-IgE-dependent secretion after IgE-dependent enhancement of mast cell IgE-bindi...
- Arachidonic acid metabolism in the human mast cell line HMC-1: 5-lipoxygenase gene expression and biosynthesis of thromboxane.
- ATP modulates anti-IgE-induced release of histamine from human lung mast cells.
- Membrane marker characterization of the eosinophil colony-forming cell.
- The eosinophil leukocyte: maturation and function.
- Extracellular deposition of eosinophil granule major basic protein in lymph nodes of patients with Hodgkin's disease.
- Tumor necrosis factor alpha and interleukin-1 beta mRNA expression in HMC-1 cells: differential regulation of gene product expression by recombinant interleukin-4.
- Activating mutations of the c-kit proto-oncogene in a human mast cell leukemia cell line.
- The HMC-1 human mast cell line expresses the hepatocyte growth factor receptor c-met.
- Human HMC-1 mast cells exclusively express the Fc gamma RII subtype of IgG receptor.
- Expression of functional TrkA receptor tyrosine kinase in the HMC-1 human mast cell line and in human mast cells.
- Modulation of intercellular adhesion molecule 1 (ICAM-1) expression on the human mast-cell line (HMC)-1 by inflammatory mediators.
- Inhibition of keratinocyte growth in cell culture and whole Skin culture by mast cell mediators.
- IL-4 enhances IL-3 and IL-8 gene expression in a human leukemic mast cell line.
- Epidemiology of anaphylaxis in Olmsted County: A population-based study.
- Interleukin 4 promotes expression of mast cell ICAM-1 antigen.
- Immunotherapy with short ragweed fraction A:D-glutamic acid:D-lysine polymer in ragweed hay fever.
- Effects of glucocorticoids on eosinophil colony growth.
- Allergen-controlled study of intranasal immunotherapy for ragweed hay fever.
- Mast cells, neutrophils, and eosinophils in prurigo nodularis.
- In vitro sensitivity of immature human mast cells to chemotherapeutic agents.
- Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit p...
- Sequestration of eosinophil major basic protein in human mast cells.
- Treatment of systemic mast-cell disease with cladribine.
- Elevated serum levels of calcitonin gene-related peptide in Hymenoptera sting-induced anaphylaxis.
- Phenotypic characterization of the human mast-cell line HMC-1.
- Urticaria and angioedema from cyclooxygenase-2 inhibitors.
- Response of severe systemic mastocytosis to interferon alpha.
- Nodules, eosinophilia, rheumatism, Dermatitis and swelling (NERDS): a novel eosinophilic disorder.
- Interferon treatment for hypereosinophilic syndromes and systemic mastocytosis.
- Induction of L-histidine decarboxylase in a human mast cell line, HMC-1.
- Stem cell factor-induced downregulation of c-kit in human lung mast cells and HMC-1 mast cells.
- Diverse clinical outcomes of eosinophilic patients with T-cell receptor gene rearrangements: the emerging diagnostic importance of molecular genetics testing.
- Stem cell factor is a chemotactic factor for human mast cells.
- Eosinophil differentiation of human umbilical cord mononuclear cells and prolonged survival of mature eosinophils by murine EL-4 thymoma cell conditioned medium.
- Increased plasma calcitonin levels in systemic mast cell disease.
- Purification of tryptase from a human mast cell line.
- Treatment of systemic mast cell disease with 2-chlorodeoxyadenosine.
- Establishment of an immature mast cell line from a patient with mast cell leukemia.
- Interferon-alpha treatment of six patients with the idiopathic hypereosinophilic syndrome.
- ''Idiopathic'' Eosinophilia with an Occult T-cell clone: prevalence and clinical course.
- Aspirin idiosyncrasy in systemic mast cell disease: a new look at mediator release during aspirin desensitization.
- Elevated serum levels of interleukin-5 in patients with the syndrome of episodic angioedema and Eosinophilia.
- Failure to detect IL-3-binding sites on human mast cells.
- Phorbol ester 12-O-tetradecanoylphorbol-13-acetate down-regulates expression of the c-kit proto-oncogene product.
- IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells.
Schools
University Of ChicagoThe Pritzker School Of Medicine
Philadelphia General Hospital
University Conn Health Center
University Of Minnesota
Procedures Preformed
- Allergy Skin Testing
Conditions Treated
- Acute Pharyngitis
- Allergic Rhinitis
- Asthma
- Chronic Sinusitis
- View All
Doctors Specialties
- Internal Medicine
- Allergy
- Immunology
Accepted Insurances
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1982681136 | |
| NPPES Provider LastName | BUTTERFIELD | |
| NPPES Provider FirstName | JOSEPH | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Allergy/Immunology | |
| Total Claim Count | 312.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1982681136 |
| Last Name Of The Provider | BUTTERFIELD |
| First Name Of The Provider | JOSEPH |
| View All |
Similar Doctors
|
|
Dr. Nancy L. Ott, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah E. Hugo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kate E. Birkenkamp, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Avni Y. Joshi, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Enrique R. Bolona, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jordan K. Schaefer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Clayton M. Spiceland, MD |
|
|
Dr. Daniel E. Maddox, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Martha F. Hartz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew I. Vaughn, MD |
|
|
Dr. Molly L. Olsen, MD |
|
|
Dr. Jennifer P. Rho, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew S. Nickels, MD
This Doctor is OpenDoctor Recommended.
|